TBP Stock Price, Chart, Stats & News

Tetra Bio-Pharma Inc.
Save
Tetra Bio-Pharma Inc. (TBP) does not currently pay a dividend.
10.58M
Market cap
–
Current P/E
–
Forward P/E
TBP chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain.
Similar securities
Based on sector and market capitalization
Report issue











